850103 | 17:1 Lyso PI
1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt)
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
17:1 Lyso PI
1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-phospho-(1'-myo-inositol) (ammonium salt)
Increased circulating levels of L-alpha-lysophosphatidylinositol (LPI) are associated with cancer and LPI is a potent ligand for the G-protein-coupled receptor GPR55.
CAS Registry Number is a Registered Trademark of the American Chemical Society
110718
Powered by BiozSong JW, Lam SM, Fan X, Cao WJ, Wang SY, Tian H, Chua GH, Zhang C, Meng FP, Xu Z, Fu JL, Huang L, Xia P, Yang T, Zhang S, Li B, Jiang TJ, Wang R, Wang Z, Shi M, Zhang JY, Wang FS, Shui G. Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis. Cell Metab. 2020 Jun 24:S1550-4131(20)30317-X. doi: 10.1016/j.cmet.2020.06.016. Epub ahead of print. PMID: 32610096; PMCID: PMC7311890.
PubMed ID: 32610096Yagi T, Kuschner CE, Shoaib M, Choudhary RC, Becker LB, Lee AT, Kim J. Relative Ratios Enhance the Diagnostic Power of Phospholipids in Distinguishing Benign and Cancerous Ovarian Masses. Cancers (Basel). 2019 Dec 26;12(1):E72. doi: 10.3390/cancers12010072. PMID: 31888002.
PubMed ID: 31888002Yagi T, Shoaib M, Kuschner C, Nishikimi M, Becker LB, Lee AT, Kim J. Challenges and Inconsistencies in Using Lysophosphatidic Acid as a Biomarker for Ovarian Cancer. Cancers (Basel). 2019 Apr 11;11(4). pii: E520. doi: 10.3390/cancers11040520.
PubMed ID: 30979045Zhu X, Gan-Schreier H, Otto AC, Cheng Y, Staffer S, Tuma-Kellner S, Ganzha A, Liebisch G, Chamulitrat W. iPla2β deficiency in mice fed with MCD diet does not correct the defect of phospholipid remodeling but attenuates hepatocellular injury via an inhibition of lipid uptake genes. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 May;1864(5):677-687. doi: 10.1016/j.bbalip.2019.02.003. Epub 2019 Feb 5.
PubMed ID: 30735854Otto AC, Gan-Schreier H, Zhu X, Tuma-Kellner S, Staffer S, Ganzha A, Liebisch G, Chamulitrat W. Group VIA phospholipase A2 deficiency in mice chronically fed with high-fat-diet attenuates hepatic steatosis by correcting a defect of phospholipid remodeling. Biochim Biophys Acta Mol Cell Biol Lipids. 2019 May;1864(5):662-676. doi: 10.1016/j.bbalip.2019.01.012. Epub 2019 Feb 5.
PubMed ID: 30735855Inloes JM, Jing H, Cravatt BF. The Spastic Paraplegia-Associated Phospholipase DDHD1 Is a Primary Brain Phosphatidylinositol Lipase. Biochemistry. 2018 Sep 17. doi: 10.1021/acs.biochem.8b00810. [Epub ahead of print]
- Certificate of Analysis (Lot No. 850103P-100UG-C-010 and 5589PDC010)
- Certificate of Analysis (Lot No. 850103P-500UG-A-010 and 5589PFA010)
- Certificate of Analysis (Lot No. 850103P-100UG-A-011 and 5589PDA011)
- Certificate of Analysis (Lot No. 850103P-500UG-A-011 and 5589PFA011)
- Certificate of Analysis (Lot No. 850103P-100UG-B-011 and 5589PDB011)
- Certificate of Analysis (Lot No. 850103P-500UG-C-011 and 5589PFC011)
- Certificate of Analysis (Lot No. 850103P-100UG-C-011 and 5589PDC011)
